resveratrol has been researched along with Cognitive Decline in 45 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 19 (42.22) | 24.3611 |
2020's | 26 (57.78) | 2.80 |
Authors | Studies |
---|---|
Calazans, MO; De Oliveira, ACP; Ribeiro, R; Santos, AC; Vieira, LB | 1 |
Augusto, MCM; Bondan, EF; Cardoso, CV; Dias, EN; Kiel, SG; Martins, MFM; Medeiros, LS; Moretti, RL; Rodrigues, PS; Sampaio, ACS; Suffredini, IB | 1 |
Aggarwal, NB; Akhter, J; Arora, I; Junaid Bashir, D; Manzoor, S; Rastogi, S; Samim, M; Siddiqui, MA | 1 |
Hou, S; Shi, X; Teng, D; Yu, D; Zhao, XY | 1 |
El-Sayed, NS; Elatrebi, S; Ibrahim, HF; Omar, EM; Said, R | 1 |
Deng, K; Lin, N; Meng, QP; Teng, D; Yu, D; Zhao, XY | 1 |
An, L; Han, T; Jin, M; Liu, F; Song, B; Wang, Z; Zhang, L; Zhang, X | 1 |
Hu, Y; Liu, Y; Wang, J; Wang, JC; Xu, JX; Zhang, Q; Zhu, LY | 1 |
Bo, H; Liu, S; Lv, G; Wang, S; Wang, Y; Yan, B; Yang, Y; Ye, C; Yin, Y; Yuan, J; Zhang, W | 1 |
Li, Z; Mei, J; Wang, Y; Yang, L; Zheng, G | 1 |
Guo, YX; He, TY; Li, HZ; Li, Z; Liu, X; Tang, M; Wang, XL; Zhao, S | 1 |
Fan, X; Song, M; Tu, W | 1 |
Balasubramanian, P; Csipo, T; Csiszar, A; Kiss, T; Lipecz, A; Nyúl-Tóth, Á; Tarantini, S; Ungvari, Z; Wiedenhoeft, T; Yabluchanskiy, A | 1 |
Biella, S; Colombo, F; Fradera, U; Lorenzo, CD; Restani, P; Ruf, JC; Stockley, C; Teissedre, PL | 1 |
Beauvieux, MC; Bouzier-Sore, AK; Chateil, JF; Deffieux, D; Dumont, U; Olivier, B; Pellerin, L; Quideau, S; Roumes, H; Sanchez, S | 1 |
Hsu, MH; Huang, LT; Lin, IC; Sheen, JM; Tain, YL; Tiao, MM; Yu, HR | 1 |
Chen, N; He, C; He, X; Li, Y; Liu, Q; Liu, S; Xiao, P; Yi, F | 1 |
Chen, S; Ding, H; Han, Y; Li, X; Li, Y; Liu, X; Wen, M; Zeng, H | 1 |
Crawford, JD; Khorshidi, F; Liu, Y; Lo, JW; Poljak, A; Sachdev, PS | 1 |
Corpas, R; Gatius, A; Griñán-Ferré, C; Pallàs, M; Rodríguez-Farré, E; Sanfeliu, C; Sarroca, S; Vilchez, D | 1 |
Li, S; Luo, A; Sun, R; Tang, X; Yan, J; Yu, H; Zhang, J; Zhao, Y; Zheng, H; Zhou, B | 1 |
Fang, G; Li, SY; Luo, AL; Sun, R; Tang, XL; Wang, X; Yan, J; Zhao, YL; Zhou, Z | 1 |
Chen, T; Guo, Y; Pan, D; Wu, Z; Zeng, X; Zhao, G | 1 |
Andres-Lacueva, C; Bellver-Sanchis, A; Chillón, M; Corpas, R; Griñán-Ferré, C; Izquierdo, V; Pallàs, M; Roig-Soriano, J; Sanfeliu, C; Somogyvári, M; Sőti, C | 1 |
Dhar, P; Kaler, S; Kaur, B; Mehta, K; Pandey, KK | 1 |
Ba, Y; Cheng, X; Huang, H; Li, Q; Liu, M; Wang, R; Wu, Y; Wu, Z; Zhang, H; Zhou, G | 1 |
Deng, Y; Hu, X; Xu, Y; Zhou, Q | 1 |
Lange, KW; Li, S | 1 |
Chen, ZJ; Yang, DH; Yang, YF; Zhang, YT | 1 |
Cheng, J; Qiu, W; Shi, Z; Xiao, G; Zhang, N | 1 |
Dong, CM; Ho, LC; Lam, CTW; Shi, DD; Wang, XM; Wu, EX; Zhang, ZJ; Zhou, XD; Zhou, ZJ | 1 |
Qu, C; Shen, J; Sun, H; Xu, L; Zhang, J | 1 |
Cao, W; Dou, Y; Li, A | 1 |
Barbagallo, M; Dominguez, LJ | 1 |
Aoyama, B; Eguchi, S; Iwata, H; Kawano, T; Locatelli, FM; Nishigaki, A; Shigematsu-Locatelli, M; Tateiwa, H; Yamanaka, D; Yokoyama, M | 1 |
Ge, S; Wang, B; Xiong, W; Xue, Z | 1 |
Lamuela-Raventós, RM; Laveriano-Santos, EP; Marhuenda-Muñoz, M; Ramírez-Garza, SL; Storniolo, CE; Tresserra-Rimbau, A; Vallverdú-Queralt, A | 1 |
Duruksu, G; Eraldemir, FC; Gocmez, SS; Polat, S; Şahin, TD; Utkan, T; Yazir, Y | 1 |
Canudas, AM; Griñán-Ferré, C; Izquierdo, V; López-Ruiz, S; Pallàs, M; Palomera-Ávalos, V | 1 |
Agapouda, A; Eckert, A; Grimm, A; Lejri, I | 1 |
Cao, K; Chen, C; Feng, Z; Li, H; Li, Y; Liu, J; Long, J; Peng, Y; Xu, J; Zheng, A; Zou, X | 1 |
Bredesen, DE; Fiala, M; Halder, RC; Porter, V; Ross, O; Sagong, B; Sayre, J | 1 |
Gacar, G; Gacar, N; Gocmez, SS; Scarpace, PJ; Tumer, N; Utkan, T | 1 |
An, R; Dang, H; Geng, T; Liang, X; Liu, Y; Ren, G; Tian, X; Yin, L | 1 |
Camins, A; Griñán-Ferré, C; Izquierdo, V; Pallàs, M; Palomera-Ávalos, V; Sanfeliu, C | 1 |
10 review(s) available for resveratrol and Cognitive Decline
Article | Year |
---|---|
Is resveratrol a prospective therapeutic strategy in the co-association of glucose metabolism disorders and neurodegenerative diseases?
Topics: Alzheimer Disease; Cognitive Dysfunction; Diabetes Mellitus, Type 2; Humans; Neurodegenerative Diseases; Resveratrol | 2022 |
Does resveratrol improve cognition in humans? A scientometric study to an in-depth review.
Topics: Affect; Aged; Alzheimer Disease; Cognition; Cognitive Dysfunction; Female; Humans; Infant, Newborn; Resveratrol; Young Adult | 2023 |
Grapes and their derivatives in modulation of cognitive decline: a critical review of epidemiological and randomized-controlled trials in humans.
Topics: Cognition; Cognitive Dysfunction; Humans; Randomized Controlled Trials as Topic; Resveratrol; Vitis; Wine | 2021 |
Resveratrol: A "miracle" drug in neuropsychiatry or a cognitive enhancer for mice only? A systematic review and meta-analysis.
Topics: Animals; Cognitive Dysfunction; Mice; Neuropsychiatry; Nootropic Agents; Pharmaceutical Preparations; Resveratrol | 2021 |
The pleiotropic neuroprotective effects of resveratrol in cognitive decline and Alzheimer's disease pathology: From antioxidant to epigenetic therapy.
Topics: Aged; Alzheimer Disease; Antioxidants; Cognitive Dysfunction; Epigenesis, Genetic; Humans; Neuroprotective Agents; Oxidative Stress; Resveratrol | 2021 |
Resveratrol, pterostilbene, and dementia.
Topics: Alzheimer Disease; Animals; Antioxidants; Biological Transport; Blood-Brain Barrier; Brain; Clinical Trials as Topic; Cognitive Dysfunction; Dementia; Disease Models, Animal; Humans; Maze Learning; Neuroprotective Agents; Resveratrol; Stilbenes | 2018 |
Resveratrol Boosts Cognitive Function by Targeting SIRT1.
Topics: Animals; Apoptosis; Autophagy; Cognition; Cognitive Dysfunction; Humans; Resveratrol; Sirtuin 1; Stilbenes | 2018 |
Nutritional prevention of cognitive decline and dementia.
Topics: Antioxidants; Autophagy; Caffeine; Catechin; Central Nervous System Stimulants; Chocolate; Cognitive Dysfunction; Curcumin; Dementia; Diet; Fatty Acids, Omega-3; Garlic; Ginkgo biloba; Healthy Aging; Humans; Inflammation; Magnesium; Oxidative Stress; Phytoestrogens; Phytotherapy; Resveratrol; Tea; Vitamins | 2018 |
Health Effects of Resveratrol: Results from Human Intervention Trials.
Topics: Biological Availability; Cardiovascular Diseases; Cognitive Dysfunction; Diabetes Mellitus, Type 2; Humans; Resveratrol | 2018 |
Mitochondria- and Oxidative Stress-Targeting Substances in Cognitive Decline-Related Disorders: From Molecular Mechanisms to Clinical Evidence.
Topics: Alzheimer Disease; Animals; Antioxidants; Clinical Trials as Topic; Cognitive Dysfunction; Drug Evaluation, Preclinical; Energy Metabolism; Evidence-Based Medicine; Ginkgo biloba; Humans; Mitochondria; Oxidative Stress; Phytoestrogens; Plant Extracts; Pregnanolone; Resveratrol | 2019 |
35 other study(ies) available for resveratrol and Cognitive Decline
Article | Year |
---|---|
Behavioral and morphological effects of resveratrol and curcumin in rats submitted to doxorubicin-induced cognitive impairment.
Topics: Animals; Cognitive Dysfunction; Curcumin; Doxorubicin; Male; Quality of Life; Rats; Rats, Wistar; Resveratrol | 2021 |
Resveratrol loaded nanoparticles attenuate cognitive impairment and inflammatory markers in PTZ-induced kindled mice.
Topics: Animals; Antioxidants; Cognitive Dysfunction; Collagen; Disease Models, Animal; Epilepsy; Glutathione; Hippocampus; Humans; Male; Mice; Nanoparticle Drug Delivery System; Oxidative Stress; Pentylenetetrazole; Resveratrol | 2021 |
Resveratrol reduces p38 mitogen-activated protein kinase phosphorylation by activating Sirtuin 1 to alleviate cognitive dysfunction after traumatic brain injury in mice.
Topics: Animals; Brain Injuries, Traumatic; Cognitive Dysfunction; Male; Mice; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Resveratrol; Sirtuin 1 | 2022 |
Potential mechanisms underlying the association between type II diabetes mellitus and cognitive dysfunction in rats: a link between miRNA-21 and Resveratrol's neuroprotective action.
Topics: Animals; Cognitive Dysfunction; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucose; Insulin; Lipids; MicroRNAs; Rats; Resveratrol; Streptozocin | 2022 |
Resveratrol activates the SIRT1/PGC-1 pathway in mice to improve synaptic-related cognitive impairment after TBI.
Topics: Animals; Brain Injuries, Traumatic; Cognitive Dysfunction; Mice; Neuroprotective Agents; Peroxisome Proliferator-Activated Receptors; Resveratrol; Sirtuin 1; Stilbenes; Synaptophysin | 2022 |
Resveratrol Ameliorates Trigeminal Neuralgia-Induced Cognitive Deficits by Regulating Neural Ultrastructural Remodelling and the CREB/BDNF Pathway in Rats.
Topics: Animals; Cognition; Cognitive Dysfunction; Elapid Venoms; Memory Disorders; Pain; Rats; Resveratrol; Trigeminal Neuralgia | 2022 |
Resveratrol improves diabetes-induced cognitive dysfunction in part through the miR-146a-5p/TXNIP axis.
Topics: Animals; Cell Cycle Proteins; Cognitive Dysfunction; Diabetes Mellitus, Experimental; MicroRNAs; Rats; Resveratrol; Tumor Necrosis Factor-alpha | 2023 |
Resveratrol glycoside mediates microglial endoplasmic reticulum stress to mitigate LPS-induced sepsis-associated cognitive dysfunction.
Topics: Animals; Cognitive Dysfunction; Endoplasmic Reticulum Stress; Glycosides; Lipopolysaccharides; Mice; Microglia; Resveratrol; Sepsis; Sepsis-Associated Encephalopathy | 2023 |
Resveratrol-loaded selenium/chitosan nano-flowers alleviate glucolipid metabolism disorder-associated cognitive impairment in Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Chitosan; Cognitive Dysfunction; Insulin Resistance; Lipopolysaccharides; Mice; Resveratrol; Selenium; tau Proteins | 2023 |
Resveratrol Improves Paclitaxel-Induced Cognitive Impairment in Mice by Activating SIRT1/PGC-1α Pathway to Regulate Neuronal State and Microglia Cell Polarization.
Topics: Animals; Brain-Derived Neurotrophic Factor; Cognitive Dysfunction; Interleukin-10; Interleukin-4; Mice; Microglia; Paclitaxel; Resveratrol; Sirtuin 1; Transcription Factors | 2023 |
Fusogenic liposomes effectively deliver resveratrol to the cerebral microcirculation and improve endothelium-dependent neurovascular coupling responses in aged mice.
Topics: Animals; Antioxidants; Cognitive Dysfunction; Disease Models, Animal; Endothelium, Vascular; Liposomes; Mice; Mice, Inbred C57BL; Microcirculation; Neurovascular Coupling; Oxidative Stress; Resveratrol; Vasodilation | 2019 |
Maternal alcoholism and neonatal hypoxia-ischemia: Neuroprotection by stilbenoid polyphenols.
Topics: Alcohol Drinking; Alcoholism; Animals; Animals, Newborn; Brain; Brain Injuries; Cognitive Dysfunction; Female; Hypoxia; Hypoxia-Ischemia, Brain; Ischemia; Male; Maternal Nutritional Physiological Phenomena; Maternal-Fetal Exchange; Neuroprotection; Neuroprotective Agents; Polyphenols; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Resveratrol; Stilbenes | 2020 |
Effects of Maternal Resveratrol on Maternal High-Fat Diet/Obesity with or without Postnatal High-Fat Diet.
Topics: Adiponectin; Animals; Antioxidants; Brain-Derived Neurotrophic Factor; Cognitive Dysfunction; Diet, High-Fat; Female; Humans; Insulin Resistance; Male; Maternal Nutritional Physiological Phenomena; Maze Learning; Obesity; Placenta; Pregnancy; Prenatal Exposure Delayed Effects; Rats, Sprague-Dawley; Resveratrol; Weaning | 2020 |
Resveratrol oligomers from Paeonia suffruticosa protect mice against cognitive dysfunction by regulating cholinergic, antioxidant and anti-inflammatory pathways.
Topics: Acetylcholinesterase; Animals; Anti-Inflammatory Agents; Antioxidants; Butyrylcholinesterase; Cholinesterase Inhibitors; Cognitive Dysfunction; Male; Maze Learning; Memory Disorders; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Paeonia; PC12 Cells; Plant Extracts; Rats; Resveratrol; Scopolamine | 2020 |
[Mechanism of resveratrol on ameliorating the cognitive dysfunction induced by sepsis associated encephalopathy in rats].
Topics: Animals; Blood-Brain Barrier; Claudin-5; Cognitive Dysfunction; Male; Rats; Rats, Sprague-Dawley; Resveratrol; Sepsis-Associated Encephalopathy | 2020 |
Resveratrol confers neuroprotection against high-fat diet in a mouse model of Alzheimer's disease via modulation of proteolytic mechanisms.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Protein Precursor; Animals; Brain; Cognitive Dysfunction; Diet, High-Fat; Disease Models, Animal; Fatty Acids; Humans; Male; Memory Disorders; Mice; Mice, Transgenic; Neuroprotection; Neuroprotective Agents; Obesity; Proteasome Endopeptidase Complex; Proteolysis; Resveratrol; Ubiquitin | 2021 |
Resveratrol Mitigates Hippocampal Tau Acetylation and Cognitive Deficit by Activation SIRT1 in Aged Rats following Anesthesia and Surgery.
Topics: Acetylation; Acetyltransferases; Aging; Anesthesia; Animals; Cells, Cultured; Cognition; Cognitive Dysfunction; Enzyme Activation; Hippocampus; Male; Mice; Postoperative Complications; Protein Processing, Post-Translational; Rats; Rats, Sprague-Dawley; Resveratrol; Sirtuin 1; Surgical Procedures, Operative; tau Proteins | 2020 |
Resveratrol ameliorates sevoflurane-induced cognitive impairment by activating the SIRT1/NF-κB pathway in neonatal mice.
Topics: Anesthetics, Inhalation; Animals; Animals, Newborn; Anti-Inflammatory Agents; Cognitive Dysfunction; Female; Hippocampus; Interleukin-6; Male; Mice; Mice, Inbred C57BL; Microglia; Neuroprotective Agents; Neurotoxicity Syndromes; NF-kappa B; Resveratrol; Sevoflurane; Sirtuin 1; Tumor Necrosis Factor-alpha | 2021 |
Resveratrol and organic selenium-rich fermented milk reduces D-galactose-induced cognitive dysfunction in mice.
Topics: Animal Feed; Animals; Arachis; Brain-Derived Neurotrophic Factor; Cognitive Dysfunction; CREB-Binding Protein; Cultured Milk Products; Extracellular Signal-Regulated MAP Kinases; Galactose; Mice; Organoselenium Compounds; Resveratrol | 2021 |
Resveratrol attenuates arsenic-induced cognitive deficits via modulation of Estrogen-NMDAR-BDNF signalling pathway in female mouse hippocampus.
Topics: Animals; Arsenic; Brain-Derived Neurotrophic Factor; Cognition; Cognitive Dysfunction; Estrogens; Female; Hippocampus; Maze Learning; Mice; Resveratrol | 2021 |
Resveratrol reverses hippocampal synaptic markers injury and SIRT1 inhibition against developmental Pb exposure.
Topics: Animals; Brain; Brain-Derived Neurotrophic Factor; Cognitive Dysfunction; Hippocampus; Lead; Lead Poisoning; Male; Neuronal Plasticity; Rats; Rats, Sprague-Dawley; Resveratrol; Sirtuin 1 | 2021 |
Resveratrol ameliorates neuronal apoptosis and cognitive impairment by activating the SIRT1/RhoA pathway in rats after anesthesia with sevoflurane.
Topics: Anesthesia; Animals; Apoptosis; Cognitive Dysfunction; Male; Rats; Resveratrol; Sevoflurane; Sirtuin 1 | 2022 |
Dietary Total Prenylflavonoids from the Fruits of Psoralea corylifolia L. Prevents Age-Related Cognitive Deficits and Down-Regulates Alzheimer's Markers in SAMP8 Mice.
Topics: Aging; Alzheimer Disease; Amyloid beta-Peptides; Animal Feed; Animals; Biomarkers; Brain; Cognitive Dysfunction; Cytokines; Disease Models, Animal; Flavonoids; Fruit; Glycogen Synthase Kinase 3 beta; Male; Mice; Molecular Structure; Peptide Fragments; Phosphorylation; Protein Aggregates; Psoralea; Resveratrol; Stilbenes; tau Proteins | 2018 |
Resveratrol Attenuates Cognitive Deficits of Traumatic Brain Injury by Activating p38 Signaling in the Brain.
Topics: Animals; Antioxidants; Apoptosis; Brain; Brain Injuries, Traumatic; Cognition; Cognitive Dysfunction; Female; Male; MAP Kinase Signaling System; Neuroprotective Agents; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resveratrol; Stilbenes | 2018 |
Resveratrol, a natural polyphenol, prevents chemotherapy-induced cognitive impairment: Involvement of cytokine modulation and neuroprotection.
Topics: Animals; Antineoplastic Agents; Antioxidants; Cognitive Dysfunction; Cytokines; Female; Maze Learning; Mice; Mice, Inbred C57BL; Neuroprotection; Polyphenols; Resveratrol | 2018 |
Resveratrol prevents cognitive deficits induced by chronic unpredictable mild stress: Sirt1/miR-134 signalling pathway regulates CREB/BDNF expression in hippocampus in vivo and in vitro.
Topics: Animals; Brain-Derived Neurotrophic Factor; Cognitive Dysfunction; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Hippocampus; Male; Maze Learning; MicroRNAs; Nootropic Agents; Random Allocation; Rats, Sprague-Dawley; Resveratrol; Sirtuin 1; Spatial Memory; Stilbenes; Stress, Psychological; Uncertainty | 2018 |
Resveratrol-loaded nanoemulsion prevents cognitive decline after abdominal surgery in aged rats.
Topics: Administration, Oral; Aging; Animals; Biological Availability; Cognitive Dysfunction; Cytokines; Dose-Response Relationship, Drug; Emulsions; Hippocampus; Inflammation; Inflammation Mediators; Male; Microglia; Postoperative Complications; Rats, Wistar; Resveratrol; Signal Transduction; Sirtuin 1; Stilbenes | 2018 |
Effects of resveratrol pretreatment on endoplasmic reticulum stress and cognitive function after surgery in aged mice.
Topics: Animals; Cognition; Cognitive Dysfunction; Endoplasmic Reticulum Stress; Hippocampus; Inflammation Mediators; Locomotion; Male; Memory Disorders; Mice; Mice, Inbred C57BL; Neurons; NF-kappa B; Postoperative Complications; Preoperative Care; Resveratrol; Sirtuin 1 | 2018 |
Resveratrol prevents cognitive deficits by attenuating oxidative damage and inflammation in rat model of streptozotocin diabetes induced vascular dementia.
Topics: Animals; Antioxidants; Avoidance Learning; Brain Chemistry; Cognitive Dysfunction; Cytokines; Dementia, Vascular; Diabetes Mellitus, Experimental; Encephalitis; Endothelium, Vascular; Male; Maze Learning; Motor Activity; Neuroprotective Agents; Oxidative Stress; Rats; Rats, Wistar; Resveratrol | 2019 |
Maternal Resveratrol Supplementation Prevents Cognitive Decline in Senescent Mice Offspring.
Topics: Animals; Antioxidants; Cognitive Aging; Cognitive Dysfunction; DNA Methylation; Female; Hydrogen Peroxide; Maternal-Fetal Exchange; Maze Learning; Mice; Pregnancy; Promoter Regions, Genetic; Resveratrol; Signal Transduction | 2019 |
AMPK activation prevents prenatal stress-induced cognitive impairment: modulation of mitochondrial content and oxidative stress.
Topics: AMP-Activated Protein Kinases; Animals; Antioxidants; Cell Line; Cognition; Cognitive Dysfunction; Enzyme Activation; Female; Glutathione; Hippocampus; Humans; Male; Mitochondria; NF-E2-Related Factor 2; Oxidation-Reduction; Oxidative Stress; Pregnancy; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Stress, Psychological | 2014 |
ω-3 Supplementation increases amyloid-β phagocytosis and resolvin D1 in patients with minor cognitive impairment.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Cholecalciferol; Cognitive Dysfunction; Dietary Supplements; Docosahexaenoic Acids; Fatty Acids, Omega-3; Female; Humans; Inflammation; Macrophages; Male; Mental Status Schedule; Middle Aged; Monocytes; Phagocytosis; Resveratrol; RNA, Messenger; Stilbenes | 2015 |
Protective effects of resveratrol on aging-induced cognitive impairment in rats.
Topics: Aging; Animals; Anti-Inflammatory Agents, Non-Steroidal; Avoidance Learning; Behavior, Animal; Cognitive Dysfunction; Cytokines; Disease Models, Animal; Inflammation; Male; Rats, Wistar; Resveratrol; Spatial Learning; Stilbenes | 2016 |
Resveratrol limits diabetes-associated cognitive decline in rats by preventing oxidative stress and inflammation and modulating hippocampal structural synaptic plasticity.
Topics: Animals; Antioxidants; Blood Glucose; Cognition; Cognition Disorders; Cognitive Dysfunction; Diabetes Complications; Diabetes Mellitus, Experimental; Hippocampus; Inflammation; Male; Maze Learning; Memory; Neuronal Plasticity; Oxidative Stress; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Superoxide Dismutase; Synapses | 2016 |
Metabolic Stress Induces Cognitive Disturbances and Inflammation in Aged Mice: Protective Role of Resveratrol.
Topics: 5-Methylcytosine; Animals; Biomarkers; Body Weight; Cognitive Dysfunction; Energy Intake; Gene Expression Regulation; Glucose Tolerance Test; Inflammation; Male; Maze Learning; Memory; Mice, Inbred C57BL; Neuroprotective Agents; Oxidative Phosphorylation; Oxidative Stress; Resveratrol; Stilbenes; Stress, Physiological | 2017 |